Skip to content
GenoLensGenoLens

SYN1

Chr Xp11.3-p11.23

synapsin I

MANE:
ENST00000295987.13

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    X-LINKED: hemizygous mutation in males, biallelic mutations in females
  • Early onset or syndromic epilepsy

    X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)
  • Intellectual disability

    X-LINKED: hemizygous mutation in males, biallelic mutations in females
  • Fetal anomalies

    X-LINKED: hemizygous mutation in males, biallelic mutations in females

Disease associations (Open Targets)

  • epilepsy, X-linked 1, with variable learning disabilities and behavior disorders

    0.77
  • X-linked epilepsy - learning disabilities - behavior disorders

    0.73
  • X-linked non-syndromic intellectual disability

    0.70
  • hereditary disease

    0.45
  • X-linked complex neurodevelopmental disorder

    0.37
  • epilepsy

    0.35
  • Seizure

    0.34
  • Intellectual disability

    0.31
  • autism spectrum disorder

    0.12
  • Alzheimer disease

    0.07

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Synapsin-1

Neuronal phosphoprotein that coats synaptic vesicles, and binds to the cytoskeleton. Acts as a regulator of synaptic vesicles trafficking, involved in the control of neurotransmitter release at the pre-synaptic terminal (PubMed:21441247, PubMed:23406870). Also involved in the regulation of axon outgrowth and synaptogenesis (By similarity). The complex formed with NOS1 and CAPON proteins is necessary for specific nitric-oxid functions at a presynaptic level (By similarity)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.